Albert Lai

17.8k total citations
201 papers, 9.0k citations indexed

About

Albert Lai is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Albert Lai has authored 201 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Genetics, 81 papers in Radiology, Nuclear Medicine and Imaging and 51 papers in Molecular Biology. Recurrent topics in Albert Lai's work include Glioma Diagnosis and Treatment (126 papers), MRI in cancer diagnosis (50 papers) and Advanced MRI Techniques and Applications (29 papers). Albert Lai is often cited by papers focused on Glioma Diagnosis and Treatment (126 papers), MRI in cancer diagnosis (50 papers) and Advanced MRI Techniques and Applications (29 papers). Albert Lai collaborates with scholars based in United States, Canada and Japan. Albert Lai's co-authors include Timothy F. Cloughesy, Phioanh L. Nghiemphu, Whitney B. Pope, Benjamin M. Ellingson, Linda M. Liau, Paul S. Mischel, Robert J. Harris, William H. Yong, Ian S. Trowbridge and Philip E. Branton and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Chemical Physics.

In The Last Decade

Albert Lai

193 papers receiving 8.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Albert Lai	5.0k	3.5k	2.8k	1.8k	1.2k	201	9.0k
Eric T. Wong	4.9k 1.0×	1.9k 0.6×	1.8k 0.7×	1.2k 0.7×	2.4k 1.9×	157	8.3k
Ahmed Idbaïh	5.4k 1.1×	1.4k 0.4×	3.4k 1.2×	2.6k 1.5×	1.8k 1.5×	259	9.7k
Matija Snuderl	2.6k 0.5×	1.7k 0.5×	3.2k 1.1×	2.2k 1.3×	1.4k 1.1×	188	9.2k
Andrew B. Lassman	5.8k 1.2×	2.0k 0.6×	1.9k 0.7×	1.5k 0.9×	3.0k 2.5×	191	8.8k
Daniel P. Cahill	4.2k 0.8×	1.3k 0.4×	4.3k 1.5×	2.5k 1.4×	1.5k 1.2×	176	9.7k
Stephen W. Coons	3.4k 0.7×	1.5k 0.4×	1.9k 0.7×	901 0.5×	1.2k 1.0×	148	6.9k
Donald M. O’Rourke	3.4k 0.7×	2.2k 0.6×	3.4k 1.2×	1.8k 1.0×	927 0.8×	210	8.9k
Joachim P. Steinbach	3.9k 0.8×	1.0k 0.3×	2.3k 0.8×	1.7k 1.0×	1.6k 1.3×	159	6.7k
Phioanh L. Nghiemphu	4.0k 0.8×	2.8k 0.8×	1.1k 0.4×	1.1k 0.7×	1.0k 0.9×	150	5.7k
Ryo Nishikawa	4.3k 0.9×	959 0.3×	3.3k 1.2×	1.9k 1.1×	1.7k 1.4×	201	8.4k

Countries citing papers authored by Albert Lai

Since Specialization

Citations

This map shows the geographic impact of Albert Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Lai more than expected).

Fields of papers citing papers by Albert Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Lai. The network helps show where Albert Lai may publish in the future.

Co-authorship network of co-authors of Albert Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Lai. A scholar is included among the top collaborators of Albert Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Lai. Albert Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanvito, Francesco, Catalina Raymond, Richard G. Everson, et al.. (2025). Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma. Neuro-Oncology. 27(11). 3016–3026.

Muthukrishnan, Sree Deepthi, David Wang, Alvaro G. Alvarado, et al.. (2024). Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth. Molecular Cancer Research. 22(7). 656–667. 1 indexed citations

Cho, Nicholas S., Francesco Sanvito, Vien Le, et al.. (2024). Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Neuroradiology. 66(12). 2153–2162. 2 indexed citations

Condro, Michael, Riki Kawaguchi, Yue Qin, et al.. (2024). Valproic acid targets IDH1 mutants through alteration of lipid metabolism. SHILAP Revista de lepidopterología. 2(1). 20–20.

Lai, Albert, et al.. (2024). Safety and Efficacy of Wharton’s Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study. Biomedicines. 12(4). 710–710. 3 indexed citations

Wang, Chencai, Lucy Wall, Nicholas S. Cho, et al.. (2023). QOL-17. SLEEP QUALITY DIMENSIONS IN LOW AND HIGH-GRADE GLIOMA SURVIVORS. Neuro-Oncology. 25(Supplement_5). v252–v252. 1 indexed citations

Cao, Minsong, John V. Hegde, Tania Kaprealian, et al.. (2023). Retrospective examination of pseudoprogression in IDH mutant gliomas. Neuro-Oncology Advances. 5(1).

Hagiwara, Akifumi, Catalina Raymond, Chencai Wang, et al.. (2023). Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma. Neuro-Oncology Advances. 5(1). vdad084–vdad084. 3 indexed citations

Johnson, Radia Marie, Heidi Phillips, Carlos Bais, et al.. (2020). Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma. Neuro-Oncology. 22(12). 1742–1756. 19 indexed citations

10.

Tatekawa, Hiroyuki, Akifumi Hagiwara, Hiroyuki Uetani, et al.. (2020). Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. Journal of Neuro-Oncology. 149(2). 337–346. 6 indexed citations

11.

Ventz, Steffen, Albert Lai, Timothy F. Cloughesy, et al.. (2019). Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data. Clinical Cancer Research. 25(16). 4993–5001. 52 indexed citations

12.

Yao, Jingwen, Ararat Chakhoyan, Catalina Raymond, et al.. (2019). Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T. American Journal of Neuroradiology. 40(6). 979–986. 22 indexed citations

13.

Wang, Rui, Yupeng He, Ziping Yang, et al.. (2018). Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular Cancer Therapeutics. 17(12). 2543–2550. 46 indexed citations

14.

Cox, Christopher D., Sichen Li, Fei Liu, et al.. (2018). D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant–Induced MIR148A Promoter Methylation. Molecular Cancer Research. 16(6). 947–960. 8 indexed citations

15.

Ellingson, Benjamin M., et al.. (2015). Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI. Clinical Cancer Research. 21(19). 4373–4383. 24 indexed citations

16.

Sandmann, Thomas, Richard Bourgon, Josep Garcia, et al.. (2015). Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. Journal of Clinical Oncology. 33(25). 2735–2744. 208 indexed citations

17.

Li, Sichen, Reshmi Chowdhury, Fei Liu, et al.. (2014). Tumor-Suppressive miR148a Is Silenced by CpG Island Hypermethylation in IDH1 -Mutant Gliomas. Clinical Cancer Research. 20(22). 5808–5822. 29 indexed citations

18.

Neal, Maxwell L., Andrew D. Trister, Sunyoung Ahn, et al.. (2013). Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression. Cancer Research. 73(10). 2976–2986. 49 indexed citations

19.

Lai, Albert, Anh Tran, Phioanh L. Nghiemphu, et al.. (2010). Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 29(2). 142–148. 353 indexed citations

20.

Wang, Christina H., Jason K. Rockhill, Maciej M. Mrugała, et al.. (2009). Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model. Cancer Research. 69(23). 9133–9140. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact